Scotts Miracle Gro (SMG) Stock May Be 33% Undervalued Despite Raised Guidance
Scotts Miracle-Gro sits in an awkward spot today. The intrinsic value estimate based on a Discounted Cash Flow (DCF) approach points to meaningful upside from the current US$61.72 share price, while the market multiple checks suggest the stock is not obviously cheap.
- Over the past 5 years the share price has declined about 51.6%, which means long term holders have yet to see a sustained recovery.
- Recent earnings progress and margin work, including stronger contributions from partnerships, can support the cash flow outlook, while higher input costs and freight expenses remain a clear risk to future profitability.
- With a value score of 4 out of 6, Scotts Miracle-Gro presents a mixed picture rather than a straightforward bargain or an obviously expensive stock.
The issue now is whether the DCF implied upside or the richer earnings multiples will prove to be the better guide for where Scotts Miracle-Gro should trade.
Find out why Scotts Miracle-Gro's 3.2% return over the last year is lagging behind its peers.
Is Scotts Miracle-Gro a Bargain on Cash Flow?
The Discounted Cash Flow (DCF) model here is built on cash flow projections rather than just reported earnings. For Scotts Miracle-Gro, the latest twelve month free cash flow is about $280 million, which the model treats as recovering and then growing at modest single digit rates over the next decade. On that basis, the DCF output points to an intrinsic value of about $91 per share.
Compared with the current $61.72 share price, that difference implies the stock is 32.5% undervalued. The recent Q3 earnings beat, helped by the Bonnie Plants joint venture and tighter margin work, provides some support for those cash flow assumptions, even as higher freight and commodity costs keep the risk side of the equation in focus.
Overall, the DCF work suggests Scotts Miracle-Gro currently looks undervalued relative to the cash flows it is expected to generate.
Our Discounted Cash Flow (DCF) analysis suggests Scotts Miracle-Gro is undervalued by 32.5%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.
Has Scotts Miracle-Gro Run Too Far on Earnings?
P/E is a natural yardstick for Scotts Miracle-Gro because investors tend to focus on its earnings power rather than just asset values. On this measure, the stock trades on a P/E of about 23.2x, which sits below the wider chemicals industry average of roughly 30.1x. However, compared with closer peers, where the average P/E is about 17.4x, Scotts Miracle-Gro appears more expensive.
The tailored fair P/E ratio for Scotts Miracle-Gro, which blends its earnings profile, risk and size, sits around 19.9x. That is below the current 23.2x level, so the shares trade at a premium to what this framework suggests is reasonable even after the recent Q3 earnings beat. The gap is not extreme, but it does indicate that investors are paying more for the stock relative to its assessed earnings capacity.
On the P/E multiple alone, Scotts Miracle-Gro currently appears overvalued compared with its modelled fair earnings ratio.
See what the numbers say about this price — find out in our valuation breakdown.
The Scotts Miracle-Gro Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Scotts Miracle-Gro pick up where this valuation puzzle leaves off by spelling out which paths for growth, margins and earnings would need to play out for the stock to be worth materially more or materially less than today’s price. Each one treats Scotts Miracle-Gro's fair value as a thesis about the business that you can revisit over time, and they sit on Simply Wall St's Community page.
Scotts Miracle-Gro splits opinion sharply, with community narratives pulling in very different directions on what the stock is really worth.
Bull case: 23% undervalued
"Ongoing cost savings and automation in the supply chain, with over US$100 million in cost reductions already captured toward a US$180 million target, and continued investment in robotics, AI and SKU rationalization, which management directly ties to gross margin gains, improved EBITDA and stronger free cash flow..."
Read the full Bull Case to see why Scotts Miracle-Gro could be undervalued
Bear case: 42% overvalued
"SMG’s current valuation reflects lingering skepticism: concerns over cannabis demand, consumer spending softness, and execution risk..."
Read the full Bear Case to see why Scotts Miracle-Gro could be overvalued
Do you think there's more to the story for Scotts Miracle-Gro? Head over to our Community to see what others are saying!
The Bottom Line
Scotts Miracle-Gro sits between two conflicting signals. The Discounted Cash Flow (DCF) intrinsic value points to meaningful upside if cash flows match the projections, while the P/E based view suggests the stock is already priced above its modelled fair earnings multiple. That split reflects a clash between what the cash flow profile could support over time and what current sentiment and peer comparisons are willing to pay today. The key question is whether margin improvements and cash generation are resilient enough to justify a richer multiple instead of the stock trading closer to peer valuations.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com